The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Aneurysmal Subarachnoid Hemorrhage Market Research Report 2024
Synopsis
The global Aneurysmal Subarachnoid Hemorrhage market was valued at US$ 151.9 million in 2023 and is anticipated to reach US$ 175.3 million by 2030, witnessing a CAGR of 2.0% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Aneurysmal Subarachnoid Hemorrhage, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aneurysmal Subarachnoid Hemorrhage.
Report Scope
The Aneurysmal Subarachnoid Hemorrhage market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aneurysmal Subarachnoid Hemorrhage market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aneurysmal Subarachnoid Hemorrhage companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Edge Therapeutics
Actelion Pharmaceuticals
Arbor Pharmaceuticals
Mayfield Brain & Spine
Europa Group
GE
Philips
Siemens
Trivitron
Toshiba
Segment by Type
Computed Tomography (CT) Scan
Magnetic Resonance Imaging (MRI)
Lumbar Puncture
Xanthochromia
Cerebral Angiography
Transcranial Doppler Ultrasound
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Aneurysmal Subarachnoid Hemorrhage companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Aneurysmal Subarachnoid Hemorrhage market was valued at US$ 151.9 million in 2023 and is anticipated to reach US$ 175.3 million by 2030, witnessing a CAGR of 2.0% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Aneurysmal Subarachnoid Hemorrhage, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aneurysmal Subarachnoid Hemorrhage.
Report Scope
The Aneurysmal Subarachnoid Hemorrhage market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aneurysmal Subarachnoid Hemorrhage market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aneurysmal Subarachnoid Hemorrhage companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Edge Therapeutics
Actelion Pharmaceuticals
Arbor Pharmaceuticals
Mayfield Brain & Spine
Europa Group
GE
Philips
Siemens
Trivitron
Toshiba
Segment by Type
Computed Tomography (CT) Scan
Magnetic Resonance Imaging (MRI)
Lumbar Puncture
Xanthochromia
Cerebral Angiography
Transcranial Doppler Ultrasound
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Aneurysmal Subarachnoid Hemorrhage companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Computed Tomography (CT) Scan
1.2.3 Magnetic Resonance Imaging (MRI)
1.2.4 Lumbar Puncture
1.2.5 Xanthochromia
1.2.6 Cerebral Angiography
1.2.7 Transcranial Doppler Ultrasound
1.3 Market by Application
1.3.1 Global Aneurysmal Subarachnoid Hemorrhage Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Aneurysmal Subarachnoid Hemorrhage Market Perspective (2019-2030)
2.2 Aneurysmal Subarachnoid Hemorrhage Growth Trends by Region
2.2.1 Global Aneurysmal Subarachnoid Hemorrhage Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Aneurysmal Subarachnoid Hemorrhage Historic Market Size by Region (2019-2024)
2.2.3 Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Region (2025-2030)
2.3 Aneurysmal Subarachnoid Hemorrhage Market Dynamics
2.3.1 Aneurysmal Subarachnoid Hemorrhage Industry Trends
2.3.2 Aneurysmal Subarachnoid Hemorrhage Market Drivers
2.3.3 Aneurysmal Subarachnoid Hemorrhage Market Challenges
2.3.4 Aneurysmal Subarachnoid Hemorrhage Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Aneurysmal Subarachnoid Hemorrhage Players by Revenue
3.1.1 Global Top Aneurysmal Subarachnoid Hemorrhage Players by Revenue (2019-2024)
3.1.2 Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Players (2019-2024)
3.2 Global Aneurysmal Subarachnoid Hemorrhage Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Aneurysmal Subarachnoid Hemorrhage Revenue
3.4 Global Aneurysmal Subarachnoid Hemorrhage Market Concentration Ratio
3.4.1 Global Aneurysmal Subarachnoid Hemorrhage Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Aneurysmal Subarachnoid Hemorrhage Revenue in 2023
3.5 Aneurysmal Subarachnoid Hemorrhage Key Players Head office and Area Served
3.6 Key Players Aneurysmal Subarachnoid Hemorrhage Product Solution and Service
3.7 Date of Enter into Aneurysmal Subarachnoid Hemorrhage Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Aneurysmal Subarachnoid Hemorrhage Breakdown Data by Type
4.1 Global Aneurysmal Subarachnoid Hemorrhage Historic Market Size by Type (2019-2024)
4.2 Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Type (2025-2030)
5 Aneurysmal Subarachnoid Hemorrhage Breakdown Data by Application
5.1 Global Aneurysmal Subarachnoid Hemorrhage Historic Market Size by Application (2019-2024)
5.2 Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Aneurysmal Subarachnoid Hemorrhage Market Size (2019-2030)
6.2 North America Aneurysmal Subarachnoid Hemorrhage Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2019-2024)
6.4 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Aneurysmal Subarachnoid Hemorrhage Market Size (2019-2030)
7.2 Europe Aneurysmal Subarachnoid Hemorrhage Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2019-2024)
7.4 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size (2019-2030)
8.2 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2019-2024)
8.4 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size (2019-2030)
9.2 Latin America Aneurysmal Subarachnoid Hemorrhage Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2019-2024)
9.4 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size (2019-2030)
10.2 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2019-2024)
10.4 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Edge Therapeutics
11.1.1 Edge Therapeutics Company Detail
11.1.2 Edge Therapeutics Business Overview
11.1.3 Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Introduction
11.1.4 Edge Therapeutics Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)
11.1.5 Edge Therapeutics Recent Development
11.2 Actelion Pharmaceuticals
11.2.1 Actelion Pharmaceuticals Company Detail
11.2.2 Actelion Pharmaceuticals Business Overview
11.2.3 Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Introduction
11.2.4 Actelion Pharmaceuticals Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)
11.2.5 Actelion Pharmaceuticals Recent Development
11.3 Arbor Pharmaceuticals
11.3.1 Arbor Pharmaceuticals Company Detail
11.3.2 Arbor Pharmaceuticals Business Overview
11.3.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Introduction
11.3.4 Arbor Pharmaceuticals Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)
11.3.5 Arbor Pharmaceuticals Recent Development
11.4 Mayfield Brain & Spine
11.4.1 Mayfield Brain & Spine Company Detail
11.4.2 Mayfield Brain & Spine Business Overview
11.4.3 Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Introduction
11.4.4 Mayfield Brain & Spine Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)
11.4.5 Mayfield Brain & Spine Recent Development
11.5 Europa Group
11.5.1 Europa Group Company Detail
11.5.2 Europa Group Business Overview
11.5.3 Europa Group Aneurysmal Subarachnoid Hemorrhage Introduction
11.5.4 Europa Group Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)
11.5.5 Europa Group Recent Development
11.6 GE
11.6.1 GE Company Detail
11.6.2 GE Business Overview
11.6.3 GE Aneurysmal Subarachnoid Hemorrhage Introduction
11.6.4 GE Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)
11.6.5 GE Recent Development
11.7 Philips
11.7.1 Philips Company Detail
11.7.2 Philips Business Overview
11.7.3 Philips Aneurysmal Subarachnoid Hemorrhage Introduction
11.7.4 Philips Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)
11.7.5 Philips Recent Development
11.8 Siemens
11.8.1 Siemens Company Detail
11.8.2 Siemens Business Overview
11.8.3 Siemens Aneurysmal Subarachnoid Hemorrhage Introduction
11.8.4 Siemens Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)
11.8.5 Siemens Recent Development
11.9 Trivitron
11.9.1 Trivitron Company Detail
11.9.2 Trivitron Business Overview
11.9.3 Trivitron Aneurysmal Subarachnoid Hemorrhage Introduction
11.9.4 Trivitron Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)
11.9.5 Trivitron Recent Development
11.10 Toshiba
11.10.1 Toshiba Company Detail
11.10.2 Toshiba Business Overview
11.10.3 Toshiba Aneurysmal Subarachnoid Hemorrhage Introduction
11.10.4 Toshiba Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)
11.10.5 Toshiba Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
